Initial PET studies of AD patients with [18F]flortaucipir (Figure 5a) [145] and [18F]T808 (Figure 5b) [149] revealed their preferential retention in brain areas containing PHF-tau filaments. Here, MAPT is linked to Alzheimer disease.